Drug profile · INN
thyrotropin alfa
THYROGEN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
thyrotropin alfa (THYROGEN) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN thyrotropin alfa
Brand THYROGEN
Route INJECTION
Formulation INJECTABLE
ATC code H01AB01
Originator Sanofi-aventis Healthcare Pty Ltd
Frequently asked questions
What is thyrotropin alfa?
thyrotropin alfa (THYROGEN) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for thyrotropin alfa?
THYROGEN is a marketed brand name for thyrotropin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of thyrotropin alfa?
thyrotropin alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.